Physician

Michael Wayne Chan, M.D.

According to 2025 Medicare claims, Michael Chan, M.D. (NPI: 1003841834) practices cardiology in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is MWC CARDIOVASCULAR CONSULTANTS, INC (NPI: 1821350174; TIN: 371694931) and primary practice location at 96701-4724.

Chan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,054 traditional Medicare patients, billed 4,182 HCPCS/CPT codes, and received $392,765 in Medicare payments. The top billing code was 93925 (Ultrasound of leg arteries or artery grafts). Part D data shows 3,965 prescription claims across 625 beneficiaries totaling $1,518,705 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 24 records totaling $899. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $204,161 to $392,765. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $341,010 to $1,518,705. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,154	3,775	$204,161
2016	1,115	3,800	$212,383
2017	1,067	3,643	$191,449
2018	1,102	3,520	$192,440
2019	1,040	3,584	$206,155
2020	1,009	3,124	$174,979
2021	1,065	3,806	$326,551
2022	1,052	4,161	$365,186
2023	1,030	4,258	$388,367
2024	1,054	4,182	$392,765

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	500	4,560	$341,010
2016	509	4,159	$423,327
2017	537	4,015	$600,328
2018	571	4,105	$719,021
2019	572	3,953	$879,301
2020	595	3,904	$1,084,859
2021	574	3,732	$1,132,774
2022	576	3,657	$1,248,812
2023	617	3,840	$1,424,168
2024	625	3,965	$1,518,705

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93925	Ultrasound of leg arteries or artery grafts	236	238	$199
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	371	372	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	787	1,847	$94
93922	Ultrasound study of arm and leg arteries	236	238	$76
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	570	605	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	595	45,879	$861,298
Entresto	Sacubitril/Valsartan	172	11,573	$249,049
Xarelto	Rivaroxaban	117	8,790	$158,052
Jardiance	Empagliflozin	47	2,930	$55,944
Farxiga	Dapagliflozin Propanediol	19	1,062	$19,697

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	24	$899	ASAHI INTECC CO., LTD.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Wayne Chan, M.D.?

Tedicare shows public-source Medicare data for Michael Wayne Chan, M.D. (NPI 1003841834), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Wayne Chan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Wayne Chan, M.D.?

Michael Wayne Chan, M.D. is linked to MWC CARDIOVASCULAR CONSULTANTS, INC (billing NPI 1821350174) in the available physician profile data.

Does Michael Wayne Chan, M.D. have Open Payments data?

Michael Wayne Chan, M.D. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.